Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Ig Sanita Pubbl ; 77(1): 414-425, 2021.
Article in Italian | MEDLINE | ID: mdl-33883751

ABSTRACT

OBJECTIVES: To evaluate the effectiveness and the frequency of use of a pulsed xenon ultraviolet light-emitting no-touch portable device (PX-UV), applied after perform current cleaning, in reducing environmental bacterial burden and the presence of pathogens on surfaces in the operating rooms at the Policlinico University Hospital of Foggia. DESIGN: Prospective before-and-after study with a follow up duration of four months, from May to August 2019. SETTING AND PARTICIPANTS: Two operating rooms of an Orthopaedic and a Neurosurgical ward in a 780-bed university hospital in the District of Foggia, Italy (about 600,000 inhabitants). MAIN OUTCOME MEASURES: According to the hygienic standards proposed by the Italian Workers Compensation Authority (ISPESL), the total and the average bacterial load and the presence of six pathogens were evaluated between pre- and post- PX-UV use combined with routine manual cleaning. RESULTS: The PX-UV system was applied at five distinct time points: t1: start of the experiment, t2: after 28 days, t3: after 13 days, t4: after 7 days, and t5: after 8 days (t2-t5: 28 days in total). About 16-min of PX-UV cycle showed significant reduction in the level of environmental contamination by decreasing the mean colony count by 87.5%, compliant with the standard (5< X ≤15 CFU per plat). Staphylococcus aureus and Acinetobacter baumannii that had been isolated in some of the samplings before PX-UV were no longer detected after t1, t2 and t5 treatments. Before PX-UV, the mean colony count was similar between t1 and t2 (p>0.05); after t3 and t4 treatments, it was lower before t5 in both the Orthopaedic and Neurosurgical operating rooms (= -97% and -75%, respectively; p<0,01). CONCLUSIONS: Implication for practice: PX-UV could supplement the standard cleaning process in reducing the microbial burden in the operating rooms and potentially achieving lower healthcare-associated surgical site infections rates.


Subject(s)
Cross Infection , Disinfection , Humans , Italy , Operating Rooms , Prospective Studies , Xenon
3.
J Parasitol ; 97(6): 1080-4, 2011 Dec.
Article in English | MEDLINE | ID: mdl-21740247

ABSTRACT

Toxoplasmosis is a cosmopolitan protozoan infection. Data regarding risk factors for the post-natal acquisition of Toxoplasma gondii infection in childhood are limited. We conducted a serological survey for T. gondii IgG antibodies and associated risk factors in 1,217 children 4-11-yr-old from Salvador, Brazil, using a commercial ELISA kit; antibodies were found in 17.5% of the children. Age (OR  =  2.18; 95% CI: 1.50-3.17) and maternal schooling level (OR  =  0.62; 95% CI: 0.42-0.92) were negatively associated with infection. A greater number of siblings (OR  =  1.53; 95% CI: 1.12-2.09), cat at home (OR  =  1.54; 95% CI: 1.06-2.24), house with non-treated piped water (OR  =  2.54; 95% CI: 1.22-5.31), and the absence of a flush toilet at home (OR  =  1.45; 95% CI: 1.04-2.01) were positively associated with T. gondii infection. Our data suggest that low socioeconomic levels and poor hygiene habits are important factors in favoring T. gondii infection.


Subject(s)
Antibodies, Protozoan/blood , Toxoplasma/immunology , Toxoplasmosis/epidemiology , Toxoplasmosis/transmission , Animals , Brazil , Cat Diseases/parasitology , Cat Diseases/transmission , Cats , Child , Child, Preschool , Humans , Hygiene/standards , Immunoglobulin G/blood , Logistic Models , Multivariate Analysis , Oocysts , Risk Factors , Seroepidemiologic Studies , Socioeconomic Factors , Surveys and Questionnaires , Toxoplasmosis, Animal/transmission , Urban Population
4.
Trop Med Int Health ; 16(4): 514-7, 2011 Apr.
Article in English | MEDLINE | ID: mdl-21410848

ABSTRACT

OBJECTIVE: To investigate the association between Toxocara canis infection and total IgE levels and eosinophilia in blood donors from a large Brazilian city. METHODS: Two hundred and sixty-eight blood donors from a government blood bank were tested. No helminth infection was diagnosed by parasitological stool examination. Total IgE levels and T. canis infection status were determined by ELISA. Eosinophil levels were determined using an automatic blood cell counter. RESULTS: Toxocara canis IgG antibodies were found in 124 (46.3%); 102 (38.0%) had eosinophilia ≥4% and 29 (10.8%) had eosinophilia ≥10%, respectively; 140 (52.2%) individuals had total IgE antibodies above the cut-off levels. Both total IgE and eosinophil levels ≥10% were positively associated with the infection. CONCLUSION: This study revealed a high prevalence of T. canis infection in blood donors, highlighting the need for screening for this infection. It also demonstrated that this population otherwise healthy has higher levels of blood eosinophils and total IgE and that both parameters are associated with T. canis infection.


Subject(s)
Blood Donors/statistics & numerical data , Eosinophilia/parasitology , Immunoglobulin E/blood , Toxocara canis , Toxocariasis/complications , Adult , Animals , Antibodies, Helminth/blood , Blood Banks , Brazil/epidemiology , Female , Humans , Male , Middle Aged , Prevalence , Toxocara canis/immunology , Toxocariasis/epidemiology , Toxocariasis/immunology
5.
Pediatr Pulmonol ; 10(1): 2-5, 1991.
Article in English | MEDLINE | ID: mdl-2003042

ABSTRACT

In this double blind study we evaluated the effect of a 2 months long treatment with inhaled beclomethasone dipropionate (300 micrograms/day) on methacholine responses in asthmatic children, during a period of maximal allergen exposure. Baseline values of methacholine PC20-FEV1 were 0.66 +/- 0.22 mg/mL (mean +/- SEM) in 10 children treated with the active drug and 0.78 +/- 0.21 mg/mL in 10 children treated with placebo. After 1 month of treatment PC20-FEV1 was 1.91 +/- 0.64 and 0.80 +/- 0.33 mg/mL, respectively, in the groups treated with beclomethasone versus placebo. A statistically significant reduction in bronchial hyperreactivity (PC20-FEV1, 5.49 +/- 1.86 mg/mL) but no systemic side effects were observed after 2 months of treatment with beclomethasone dipropionate. This is compared with a PC20-FEV1 of 1.38 +/- 0.52 mg/mL in the placebo group. The results confirm the effect of inhaled corticosteroids in reducing bronchial hyperreactivity, even during a period of maximal allergen exposure.


Subject(s)
Asthma/drug therapy , Beclomethasone/administration & dosage , Bronchoconstriction/drug effects , Allergens , Asthma/physiopathology , Beclomethasone/therapeutic use , Bronchial Provocation Tests , Child , Double-Blind Method , Female , Forced Expiratory Volume/drug effects , Humans , Male , Methacholine Chloride , Nebulizers and Vaporizers
SELECTION OF CITATIONS
SEARCH DETAIL
...